Skip to main content
. 2019 Feb 8;31(5):277–285. doi: 10.1093/intimm/dxz009

Fig. 1.

Fig. 1.

Serum IL-8 levels in RA patients increased after denosumab treatment. Serum cytokine or chemokine levels in RA patients who had not previously undergone bisphosphonate treatment were measured prior to and 1 month after denosumab treatment. Statistical significance was evaluated using Wilcoxon signed-rank test. CCL, chemokine ligand.